Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coherus Oncology (CHRS) Asset Utilization Ratio: 2014-2025

Historic Asset Utilization Ratio for Coherus Oncology (CHRS) over the last 11 years, with Sep 2025 value amounting to 0.58.

  • Coherus Oncology's Asset Utilization Ratio rose 211.10% to 0.58 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58, marking a year-over-year increase of 211.10%. This contributed to the annual value of 0.50 for FY2024, which is 6.89% up from last year.
  • Coherus Oncology's Asset Utilization Ratio amounted to 0.58 in Q3 2025, which was down 13.50% from 0.67 recorded in Q2 2025.
  • In the past 5 years, Coherus Oncology's Asset Utilization Ratio ranged from a high of 0.67 in Q2 2025 and a low of 0.19 during Q3 2024.
  • In the last 3 years, Coherus Oncology's Asset Utilization Ratio had a median value of 0.42 in 2023 and averaged 0.45.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 53.40% in 2024, then spiked by 211.10% in 2025.
  • Over the past 5 years, Coherus Oncology's Asset Utilization Ratio (Quarterly) stood at 0.46 in 2021, then dropped by 10.98% to 0.41 in 2022, then grew by 3.65% to 0.42 in 2023, then spiked by 32.06% to 0.56 in 2024, then spiked by 211.10% to 0.58 in 2025.
  • Its Asset Utilization Ratio stands at 0.58 for Q3 2025, versus 0.67 for Q2 2025 and 0.66 for Q1 2025.